NVS Jan 2024 85.000 call
| Previous close | 21.00 |
| Open | 21.00 |
| Bid | 16.60 |
| Ask | 21.40 |
| Strike | 85.00 |
| Expiry date | 2024-01-19 |
| Day's range | 21.00 - 21.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 780 |
ZacksNovartis (NVS) Dips More Than Broader Markets: What You Should Know
Novartis (NVS) closed the most recent trading day at $101.86, moving -0.46% from the previous trading session.
GlobeNewswireNovartis completes divestment of ‘front of eye’ ophthalmology assets
Divestment includes Xiidra®, on-market treatment for dry eye disease and additional ophthalmic investigational therapiesNovartis advances strategy of focused portfolio and prioritized therapeutic areas for future growth Basel, September 29th, 2023 — Novartis today announced that it has completed its divestment of ‘front of eye’ ophthalmology assets to Bausch + Lomb, a global eye health company, in a transaction valued up to USD 2.5 billion, consisting of 1.75 billion in upfront cash, plus potent
ZacksIonis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs
Per the agreement, Ionis (IONS) will grant exclusive global rights to Roche to develop and market two novel RNA-therapeutics for Alzheimer's and Huntington's diseases.
